Rondo Therapeutics
We are committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies.
$67M Series A ·
Led by Canaan Partners · Source: fundraisingfox.com
Funding history ↓Signals
Website registeredJun 3, 2021 (5 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $67M | fundraisingfox.com |
Timeline
- Website created
Founders and team
NT
Nathan Trinklein Chief Scientific Officer | Co-FounderLinkedIn · source: rondotx.comSF
Shelley Force Aldred Chief Executive Officer | Co-FounderLinkedIn · source: rondotx.com
Investors
CCanaan Partnerslead investor
JJohnson & Johnson Innovation
NNovo Holdings
RRed Tree Venture Capitallead investor
SSV Health Investors
Companies like Rondo Therapeutics
CCurrent SurgicalSeed · Apr 2026
AAkamis Bio$60M Series A · Dec 2024
CCatalYm$150M Series B+ · Jul 2024
BBreakthru Medicine$60M Series A · Feb 2026
33T Biosciences$40M Series A · Aug 2022
LLever Bio$10.09M Seed · Dec 2025
Other companies backed by Canaan Partners
SSetara Biosciences$90M Series A · Oct 2026
DDraig Therapeutics$65M Series B+ · Jul 2026
RRylo$85M Series B+ · Jun 2026
AArtie$12M Series A · Jan 2026
SSumble$38.5M · Oct 2025
DDoorstep$8M Seed · Sep 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/rondo-therapeutics (get a free API key).